Navigation Links
Block & Leviton LLP Investigates ISTA Pharmaceuticals, Inc.'s Board of Directors for Possible Breaches of Fiduciary Duty
Date:12/16/2011

BOSTON, Dec. 16, 2011 /PRNewswire/ -- Block & Leviton LLP is investigating whether the Board of Directors of ISTA Pharmaceuticals, Inc. ("ISTA" or the "Company") (NASDAQ: ISTA) breached their fiduciary duties by rejecting an offer from Valeant Pharmaceuticals International, Inc. ("Valeant") (NASDAQ: VRX) to acquire the Company in a proposed transaction valued at $327 million. 

The investigation centers on whether ISTA's Board of Directors protected shareholder interests, and properly maximized shareholder value, when it refused Valeant's offer to acquire the Company for approximately $6.50 per share, representing a hefty premium to ISTA's shareholders of approximately 67% over the stock's closing price of $3.89 on December 15, 2011. 

If you own stock in ISTA and want to discuss your rights with regard to ISTA's rejection of the Valeant offer, or if you have any questions, please contact Mark Alan Delaney at (617) 398-5650 or Mark@blockesq.com

The attorneys at Block & Leviton LLP have more than 40 years of experience in representing individual and institutional investors in shareholder rights actions and throughout their careers have achieved significant recoveries for their clients.

This may constitute attorney advertising.


'/>"/>
SOURCE Block & Leviton LLP
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Indiana Stop-Sale System Shows Effectiveness of Real-Time, Blocking Technology in the Fight Against Illegal Sales of Pseudoephedrine
2. Alabama Stop-Sale System Blocks Illegal Sales & Allows Legal Ones
3. DMC Cardiovascular Institute Physician is First in Michigan to Use New "Arterial Drill" Catheterization Technique to Remove a Major Blockage
4. NADDI Lauds Ohio Bill Introduction: Real-Time, Stop-Sale System Blocks Illegal Sales
5. Cardium Announces Market Introduction of New Alena™ Clinical Strength Carb Blocker to Expand the MedPodium Healthy Lifestyle Product Line
6. FDA: Treatment With Angiotensin Receptor Blockers for High Blood Pressure Does Not Increase Risk of Cancer
7. For Treatment of Irritable Bowel Syndrome, Linaclotide Will Emerge as the Market Leader and Will Achieve Blockbuster Status in 2019
8. NACDS, NCPA: Victory for Patients, Pharmacy as CMS Moves to Withdraw Provisions of AMP Rule Currently Blocked by Injunction
9. Amedica® Receives Patent for Knee Prosthesis With Monoblock Silicon Nitride Ceramic Tibial Component
10. NeoStem Comments on Recent Court Ruling Blocking the Federal Governments Funding of Embryonic Stem Cell Research
11. Block Engineering Introduces Family of Quantum Cascade Laser Mid-IR Spectrometers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a ... second affiliate in Latin America . ... ... ... ...
(Date:6/23/2016)... N.J. , June 23, 2016  Guerbet announced ... Premier Inc.,s Supplier Horizon Award . ... year, Guerbet was recognized for its support of Premier ... creation through clinical excellence, and commitment to lower costs. ... to receive this recognition of our outstanding customer service ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Surgical Procedure Volumes: Global Analysis (United States, ... Australia, Canada)" report to their offering. ... an essential tool for healthcare business planners, provides surgical ... looks at surgery trends with an in-depth analysis of ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... ... 24, 2016 , ... Dr. Amanda Cheng, an orthodontist ... has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be used ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
Breaking Medicine News(10 mins):